首页>
外国专利>
COMPOSITION FOR PREDICTING THE RESPONSE TO ANTI-CANCER DRUG OF OVARIAN CANCER USING CPG METHYLATION STATUS IN PROMOTER REGION OF CDC42EP2 GENE AND USES THEREOF
COMPOSITION FOR PREDICTING THE RESPONSE TO ANTI-CANCER DRUG OF OVARIAN CANCER USING CPG METHYLATION STATUS IN PROMOTER REGION OF CDC42EP2 GENE AND USES THEREOF
展开▼
机译:利用CPG甲基化状态预测CDC42EP2基因启动子区对卵巢癌抗药性反应的组合物及其用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a composition, a kit and a method for predicting reaction of anti-cancer drug treatment of an ovarian cancer patient by detecting methylation status of a CpG portion of a CDC42EP2 effector protein (Rho GTPase binding 2) gene promotor.
展开▼